Related Experiment Video
Updated: Jun 20, 2026
10:23
Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
Meta-analysis of EEG biofeedback in treating epilepsy.
Gabriel Tan1, John Thornby, D Corydon Hammond
1Michael E. DeBakey Veterans Affairs Hospital and Baylor College of Medicine, Houston, Texas, USA. tan.gabriel@va.gov
Clinical EEG and Neuroscience
|September 1, 2009
Summary
Electroencephalographic (EEG) biofeedback, also known as neurofeedback, significantly reduces seizure frequency in epilepsy patients resistant to medication. This meta-analysis confirms its efficacy for individuals seeking alternative seizure control methods.
Area of Science:
- Neuroscience
- Clinical Neurology
- Behavioral Therapy
Background:
- Approximately one-third of epilepsy patients do not respond to conventional medical treatments.
- Electroencephalographic (EEG) biofeedback, or neurofeedback, offers a potential alternative by normalizing EEG activity through operant conditioning.
- Existing research on neurofeedback for epilepsy primarily consists of small case series, limiting definitive conclusions on efficacy.
Purpose of the Study:
- To conduct a meta-analysis of existing research on the efficacy of EEG biofeedback for epilepsy treatment.
- To evaluate the impact of neurofeedback on seizure frequency in patients with medically refractory epilepsy.
Main Methods:
- A systematic search of MedLine, PsychInfo, and PsychLit databases was performed for studies published between 1970 and 2005.
- Ten studies providing sufficient seizure frequency data were included in the meta-analysis.
- The primary outcome measure was the change in seizure frequency before and after EEG biofeedback intervention.
Main Results:
- All 10 included studies reported a decrease in seizure incidence following EEG biofeedback.
- A significant reduction in weekly seizure frequency was observed, with 74% of patients (64 out of 87) experiencing fewer seizures.
- The meta-analysis revealed a significant effect size (Hedges's g = -0.233, p<.001), indicating a positive treatment outcome.
Conclusions:
- EEG biofeedback, a form of operant conditioning, is an effective intervention for reducing seizure frequency in epilepsy patients.
- This finding is particularly significant for patients who have not benefited from standard pharmacological treatments.
- Neurofeedback represents a viable therapeutic option for managing drug-resistant epilepsy.
